Back
Atea Pharmaceuticals, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
AVIR
Atea Pharmaceuticals, Inc.
Last Price:
$5.77
Seasonality Move:
-4.95%
7 Day Trial
ALL ACCESS PASS
$
7
Atea Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Atea Pharmaceuticals, Inc. has on average historically fallen by 13.4% based on the past 5 years of stock performance.
-
Atea Pharmaceuticals, Inc. has fallen lower in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Atea Pharmaceuticals, Inc. Stock Undervalued?The current Atea Pharmaceuticals, Inc. [AVIR] share price is $5.76. The Score for AVIR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
AVIR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Atea Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Atea Pharmaceuticals, Inc. has on average historically fallen by 13.4% based on the past 5 years of stock performance.
Atea Pharmaceuticals, Inc. Stock Rating
Sell
34
Atea Pharmaceuticals, Inc. (AVIR)
is a Sell
Is Atea Pharmaceuticals, Inc. overpriced?
-
Atea Pharmaceuticals, Inc. has fallen lower in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Atea Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
ateapharma.com
52-Week Data
52-Week High:
6.45
52-Week Low:
2.46
Prediction Charts
Market Cap:
468.7M
Price in USD:
5.76
Volume:
442.9K
Beta:
0.11
Technical Analysis
SMA50:
4.93
SMA100:
4.10
SMA200:
3.72
52-Wk Change:
100%
Stock Predictions
-
Is Atea Pharmaceuticals, Inc. stock public?Yes, Atea Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Atea Pharmaceuticals, Inc. stock quote today?The Atea Pharmaceuticals, Inc. stock price is 5.76 USD today.
-
How to buy Atea Pharmaceuticals, Inc. stock online?You can buy Atea Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-16 | 6.10 | 6.05 | 6.18 | 5.88 |
| Mar-17 | 6.04 | 6.13 | 6.19 | 6.00 |
| Mar-18 | 6.09 | 5.91 | 6.09 | 5.79 |
| Mar-19 | 5.86 | 6.00 | 6.07 | 5.85 |
| Mar-20 | 5.97 | 5.66 | 6.05 | 5.64 |
| Mar-23 | 5.73 | 5.57 | 5.73 | 5.45 |
| Mar-24 | 5.51 | 5.33 | 5.54 | 5.05 |
| Mar-25 | 5.37 | 5.43 | 5.51 | 5.34 |
| Mar-26 | 5.34 | 5.33 | 5.51 | 5.32 |
| Mar-27 | 5.33 | 5.12 | 5.40 | 5.08 |
| Mar-30 | 5.10 | 5.08 | 5.14 | 5.03 |
| Mar-31 | 5.13 | 5.38 | 5.40 | 5.13 |
| Apr-1 | 5.41 | 5.65 | 5.70 | 5.33 |
| Apr-2 | 5.50 | 5.76 | 5.84 | 5.50 |
Atea Pharmaceuticals, Inc. Earnings
Atea Pharmaceuticals, Inc. Earnings Report: Per Share Atea Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Atea Pharmaceuticals, Inc. Forecast Revenue Growth
Atea Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Atea Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.21 per share, and an increase next year of $0.55 per share.
* Atea Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.